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STUDY SELECTION
Randomized trials that compared preventive antibiotic therapy versus control in patients with acute ischemic or hemorrhagic stroke were included. There were no limits on route of antibiotic administration (oral or parenteral) or duration, but therapy had to be started within 24 hours after the onset of stroke in patients without infection at presentation.
DATA EXTRACTION AND SYNTHESIS
Two authors independently extracted data with a standardized data collection form. Discrepancies were resolved by consensus with a third author. Bias was assessed with specific infectious processes (eg, pneumonia) or mortality. Overall, the quality of the evidence was high. However, studies were heterogeneous; with 2 of the 8 studies, risk of bias was considered to be high for 3 out of 6 criteria.
Commentary
Infections complicate 30% of strokes, 1 most commonly pneumonia (11% to 22%) 2 and urinary tract infection (16% to 24%). 3 Preventing these infections through prophylactic antibiotics could improve patient outcomes. These benefits are offset by the risk of anaphylaxis, toxicity to various organs, and colonization by antibiotic-resistant organisms. In this meta-analysis of 8 studies, prophylactic antibiotics decreased the rate of urinary tract infections, but did not affect the rate of pneumonia. Prophylactic antibiotics also did not confer any protection against mortality or functional dependence. For this reason, preventive antibiotic therapy is not recommended as a therapeutic option for acute stroke. 4 The 2018 acute stroke guidelines 5 state that routine use of prophylactic antibiotics has not been shown to be beneficial. However, these data may be useful to the practicing emergency department (ED) provider who may be caring for stroke patients beyond the acute phase or asked to assist in managing them in places such as rural locations and practices in which there is no stroke unit, where neurology coverage is minimal. Often, the ED provider may be the only specialist treating the patient during the initial 24-hour period.
This study has several limitations. Among the more than 4,000 patients studied, no adverse events related to anaphylaxis or toxicity were reported, possibly because most randomized controlled trials are not powered to detect statistically significant differences in adverse events. Future work examining the adverse events in this population may be helpful. Although specific subgroups may benefit from prophylactic antibiotics, the current meta-analysis was not able to pool data to specific at-risk subgroups, including those based on stroke severity, whether patients had urinary catheters at baseline or immediately on admission (versus not at all), or whether patients were bedridden at baseline.
Although prophylactic antibiotics help to reduce the rate of overall infections-specifically, urinary tract infections-in patients with acute ischemic or hemorrhagic stroke, they do not reduce the risk of pneumonia, death, or dependency after acute stroke and are not currently recommended as routine therapy for these patients.
